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Abstract 
The FMR1 gene contains an unstable CGG repeat in its 5’ untranslated region. Premutation 
alleles range between 55 and 200 repeat units and confer a risk for developing fragile X-
associated tremor/ataxia syndrome or fragile X-associated primary ovarian insufficiency. 
Furthermore, the premutation allele often expands to a full mutation during female germline 
transmission giving rise to the fragile X syndrome. The risk for a premutation to expand 
depends mainly on the number of CGG units and the presence of AGG interruptions in the 
CGG repeat. Unfortunately, the detection of AGG interruptions is hampered by technical 
difficulties. Here, we demonstrate that single-molecule sequencing enables the determination 
of not only the repeat size, but also the complete repeat sequence including AGG 
interruptions in male and female alleles with repeats ranging from 45 to 100 CGG units. We 
envision this method will facilitate research and diagnostic analysis of the FMR1 repeat 
expansion.  
Keywords 
single-molecule sequencing, fragile X syndrome, AGG interruption, premutation repeats, 
gray-zone repeats, CGG repeat, repeat expansion disease 
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Introduction 
The fragile X mental retardation gene (FMR1; MIM *309550) is located on band q27.3 of the 
X chromosome and contains a CGG tandem repeat in its 5’ untranslated region 
(UTR)(Harrison et al. 1983; Verkerk et al. 1991). The size of the CGG repeat is variable and 
this characteristic is used to classify the repeats into 4 categories: normal (<45 units), gray-
zone (45-54 units), premutation (55-200 units) and full mutations (>200 units)(Biancalana et 
al. 2015). The repeat size influences the instability of the repeat and also the phenotype of the 
individual will be different. Carriers of a gray-zone allele have a normal phenotype. The 
small repeats of this category might be unstable upon transmission, but they rarely expand 
into a premutation allele (Biancalana et al. 2015). In contrast, individuals carrying a 
premutation allele are at risk for developing the late-onset neurodegenerative disorder fragile 
X-associated tremor/ataxia syndrome (FXTAS; MIM #300623) or fragile X-associated 
primary ovarian insufficiency (FXPOI; MIM #311360) (Sullivan et al. 2005; Hagerman and 
Hagerman 2013). Moreover, female premutation carriers are at risk of transmitting a full 
mutation (>200 CGG units) to their offspring (Oberlé et al. 1991; Yu et al. 1991; 
Penagarikano et al. 2007). This large expansion induces abnormal methylation of the 
promoter of the FMR1 gene which disrupts the production of the Fragile X Mental 
Retardation Protein (FMRP)(Pieretti et al. 1991). The absence of FMRP causes the fragile X 
syndrome (FXS; MIM #300624) which is the most frequent monogenic cause of X-linked 
Intellectual Disability (XLID) and autism. Other phenotypes often observed in patients with 
FXS are hypersensitivity, hyperactivity, attention deficit and mild dysmorphic features 
(Penagarikano et al. 2007; Usdin et al. 2014).  
Due to the severity of the FXS, an accurate estimate of the risk for a woman with a 
premutation allele to transmit a full mutation to her offspring is crucial in genetic counseling. 
For example, a woman with a high risk can decide to choose for preimplantation genetic 
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diagnosis (PGD) where one could select for unaffected males or non-carrier female embryos 
(Sermon et al. 1999; Burlet et al. 2006). On the other hand, women with only a minor risk 
would choose for normal conception, optionally in combination with prenatal diagnosis to 
monitor the fragile X status of their fetus (Biancalana et al. 2015). With an incidence of about 
1 in 200 females carrying a premutation allele, this is a pertinent question in genetic 
counseling (Tassone et al. 2012). 
The risk of a premutation to expand to a full mutation depends mainly on the size of the 
premutation allele, whereby larger alleles expand faster into full mutations. For example, 
alleles larger than 100 CGG repeat units have a risk of almost 100% to expand into a full 
mutation. In contrast, small premutation alleles (55 to 59 CGG units) have only 3% 
expansion risk to a full mutation and alleles ranging between 60 and 100 CGG tandem 
repeats have intermediate risks (Yrigollen et al. 2012). The FMR1 CGG repeat is often 
interrupted by 1-4 AGGs clustered towards the 5’ end. It has been shown that AGG 
interruptions will increase the stability and reduce the risk for expansions. (Eichler et al. 
1994; Nolin et al. 2014). Large population studies indicate that the risk reduction of AGGs is 
the biggest for repeat sizes between 55 and 85 CGG units (Nolin et al. 2014; Yrigollen et al. 
2014). For example, for a woman with 75 repeats interspersed with 2 AGG units the risk to 
transmit a full mutation to her offspring is 12% but increases to 77% if AGG interruptions are 
present(Yrigollen et al. 2012). For alleles smaller than 55 there is no risk difference with or 
without AGG interruptions. The differential risk reduces to less than 38% for alleles larger 
than 85 CGG units. Since for those large alleles the overall risk for an expansion is larger 
than 50% irrespective of the number of AGG interruptions, the clinical importance of 
mapping the interruptions in larger expansions drops. Hence, mapping the location and 
number of AGGs within the CGG repeat is essential for an accurate risk prediction and 
genetic counseling, especially for alleles with 55-85 CGG units. However, AGG 
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measurement is not yet a standard feature of FRM1 diagnostic work-up in most laboratories 
worldwide (Jacquemont et al. 2011; Monaghan et al. 2013; Biancalana et al. 2015). 
Measurement of AGG interruptions has been hampered by technical difficulties. Traditional 
Southern blotting cannot localize the AGG interruptions. If determined, AGG interruptions 
are detected by a Triplet-Primed PCR (TP-PCR)(Chen et al. 2010). This is an indirect method 
whereby the forward and reverse primer of a standard PCR are complemented with a third 
primer which will anneal right into the repeat. By adding the third primer, the PCR will 
produce a ladder of peaks which will be visible on an agarose gel as a smear. The main 
advantage of this technique is that it indicates if a full mutation is present in an individual, 
even if the full mutation cannot be completely amplified. An additional advantage of TP-PCR 
is that it also points out the presence of AGG units in premutation carriers: if an AGG unit is 
present in the repeat, the third primer will fail to anneal at that particular site and a gap will 
be present in the profile. TP-PCR readily identifies the number and location of AGG units 
within the CGG repeat in males because at every AGG the signal will drop to the baseline. In 
contrast, interpreting TP-PCR results in females remains challenging as they carry two X-
chromosomes each containing a different CGG repeat with a specific set of AGG units. If the 
structure of those two repeats is different, TP-PCR does not allow to resolve the repeat 
structure (Chen et al. 2010). Further analysis requires 2 additional PCR reactions to decipher 
the exact repeat structure (Nolin et al. 2013). A disadvantage for both the diagnostic and 
scientific Fragile X community is that those PCRs are intellectual property of Asuragen 
(Texas, USA) and can only be performed on site.  
In order to circumvent the various limitations of TP-PCR, we explored single-molecule 
sequencing to determine the number and location of AGG interruptions in both males and 
females carrying FMR1 premutation alleles. Single-molecule sequencing technology is able 
to sequence through large and very GC-rich repeats, including CGG repeats (Loomis et al. 
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2013; Shin et al. 2013; Chaisson et al. 2015). Furthermore, Loomis et al. (2013) proved single 
molecule sequencing enabled the detection of AGG interruptions as they showed 1 AGG unit 
embedded in a CGG repeat cloned in a plasmid. Finally, the long reads generated by single-
molecule sequencing allow to cross a circulated double-stranded template molecule multiple 
times. By making a consensus from all different passes it is possible to eliminate sequencing 
errors which are randomly distributed across the reads and generate very accurate reads-of-
insert (Carneiro et al. 2012; Jiao et al. 2013; Hestand et al. 2016).  
We demonstrate that single-molecule sequencing enables reading through repeat- and GC-
rich regions with a very high accuracy which permits reconstruction of the complete repeat 
structure for gray zone and premutation alleles, not only for males, but also for females.  
Materials and Methods 
DNA samples. The structure of the CGG repeat in the FMR1 gene (Genebank Accession 
number NG_007529.2) was determined for 7 males (2 gray zone alleles, 5 premutation 
alleles) and 34 females (5 females with a normal and a gray zone allele, 28 females with a 
normal and a premutation allele and 1 female with 2 premutation alleles). The patients were 
referred for diagnostic testing because of either FXTAS, POI or because of a family history 
of FXS. The premutation alleles varied between 45 and 100 CGG units according to PCR. 
After informed consent was obtained from the patients, DNA was isolated from peripheral 
white blood cells according to standard procedures. This study was approved by the local 
ethics committee. 
Amplicon generation. First, the FMR1 CGG repeat was amplified using the PCRX Enhancer 
System (Invitrogen, Carlsbad, CA) with 40ng/ul DNA input and previously published 
specific primers (Figure 1A)(Filipovic-Sadic et al. 2010). In order to integrate barcodes, an 
M13 tail was attached at both the forward (M13-Forward tail: 
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TGTAAAACGACGGCCAGT) and the reverse primer (M13-Reverse tail: 
CAGGAAACAGCTATGACC). Next, a reaction mixture was prepared by combining 4 µl of 
10X PCRX Amplification Buffer, 1,2 µl 50 mM MgSO4, 4 µl of 2 mM dNTPs (Invitrogen), 16 
µl of 10X PCRX Enhancer Solution, 4 µl of a 2,5 uM mixture of both forward and reverse 
primer, 10 µl of DNA and finally 0.5 µl Taq Polymerase (Invitrogen). After gently mixing 
the reaction, the repeat was amplified starting with a heat denaturation at 95°C for 3 minutes, 
followed by 25 cycles of 95°C for 30 seconds, 64°C for 60 seconds and 68°C for 90 seconds, 
followed by a final extension step at 72°C for 5 minutes where after the samples were stored 
at 4°C. After checking the efficiency of the PCR on a Fragment Analyser (Advanced 
Analytical, Ankeny, IA), the samples were purified with 1X washed Agencourt AMPure XP 
beads (Beckman Coulter, Brea, CA) and eluted in 11 ul of water. Next, barcoded primers 
from PacBio’s 96-well barcoding kit were attached to the amplicons by their M13 tail, which 
allowed pooling different amplicons together. The reaction mixture was prepared as 
described above, but now the purified amplicons were used as DNA input together with 
PacBio’s barcoded primers. The second PCR mixture was subsequently denatured at 95°C for 
180 seconds followed by 5 cycles of 95°C for 30 seconds, 45°C for 60 seconds and 68°C for 
90 seconds, followed by another 5 cycles of 95°C for 30 seconds, 65°C for 60 and 68°C for 
90 seconds and a final elongation step at 72°C for 5 minutes. Afterwards, the amplicons were 
again purified by 1X washed Agencourt AMPure XP beads, visualized on the Fragment 
Analyser and pooled equimolar together. By using this strategy, 3 pools with a maximum of 
24 samples were generated. 
Single Molecule Real-Time Sequencing. The pooled amplicons were prepared for 
sequencing as described in PacBio’s standard 500 bp Template Preparation and Sequencing 
protocol, using the Template Prep kit 3.0 (Pacific Biosciences, Menlo Park, CA). Hereafter 
each library was sequenced on a PacBio RS II using the DNA/Polymerase binding Kit P6 v2 
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(Pacific Biosciences) for a 360 minutes movie (Figure 1B). All runs used PacBio’s DNA 
Sequencing Reagent Kit 4.0 v2. The 3 pools were sequenced in three different sequencing 
runs. The first pool was sequenced on 2 SMRT cells, whereas pool 2 and 3 only used a single 
SMRT cell. 
De novo assembly of the CGG repeat structure.  
 Generating reads-of-insert 
The long reads generated by single-molecule cross each molecule multiple times (Figure 1C). 
Therefore demultiplexed reads-of-insert were generated with the RS_ReadsOfInsert.1 
protocol from PacBio’s SMRT portal (v2.3.0) with a minimum of 10 full passes, a minimum 
predicted accuracy of 90% and demultiplexing with symmetric barcodes (Figure 1D).  
 Selecting on-target reads 
Next, only reads-of-insert derived from the FMR1 CGG repeat were selected by aligning all 
reads-of-insert using BWA-SW v0.7.10 (Li and Durbin 2009) against the human reference 
genome hg19 downloaded from UCSC (Karolchik et al. 2004). followed by conversion of 
SAM to BAM by Samtools v1.3.1 (Li et al. 2009). To finally convert to BED format and 
select the on-target reads-of-inserts BEDtools v2.20.1 was used (Quinlan and Hall 2010).  
 Seperation of the two alleles in females 
In females we separated the normal from the premutation allele by plotting the number of 
reads as a function of read size (Figure 1C), followed by separation of the normal from the 
premutation allele based on differences of the read size (Figure 1E). This is possible because 
normal alleles contain less CGG repeat units than premutation alleles and thus generate 
shorter reads-of-inserts. Reads-of-insert derived from the normal allele are called normal 
reads and reads-of-insert originating from the premutation alleles are called premutation 
reads.  
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 De novo assembly 
Subsequently, a de novo assembly (Figure 1F) was performed on the separated normal and 
premutation reads-of-insert using MIRA v4.0 (Chevreux et al. 2004). This specific assembler 
was chosen because it was conceived especially to resolve repeats and it has been used before 
to perform de novo assembly on single-molecule sequencing data of large repetitive regions 
(Guo et al. 2014). To perform an assembly on the normal reads, MIRA was run with custom 
tuned parameters which can be found in the Supplemental Methods. Afterwards, only 
assemblies with the highest quality were selected. Ideally, this means the quality per base is 
90. A custom python script was used to extract the repeat size, the number of AGG 
interruptions and the repeat structure from the assembly and reported according to 
nomenclature described by the Human Genome Variation Society (HGVS). To control the 
assembly process, the repeat structure extracted from the de novo assembly was compared to 
the repeat characteristics (repeat size, AGG interruptions) of the individual reads-of-insert. 
All variants are submitted to the FMR1 locus-specific database which can be found at 
http://www.lovd.nl/FMR1 (Fokkema et al. 2011).  
Determination of the precision and robustness of AGG interruption detection. In order 
to describe the precision of the described AGG interruption detection method we use the 
terminology proposed by Mattocks et al. (2010). Three females were randomly selected to 
determine the repeatability (within-run precision) and the intermediate precision (between-
run precision) . To determine the repeatability, 3 amplicons of each selected female were 
included in a single run. Next, to define the intermediate precision amplicons of 3 females 
were included in 3 separate sequencing runs. Finally, the robustness of the method was tested 
by using 5, 40 and 100 ng/µl of input DNA for one female.  
Validation of the sequencing results.  
  
This article is protected by copyright. All rights reserved. 
The size and structure of the repeat determined by single-molecule sequencing was validated 
by an ‘in-house’ PCR combined with an FMR1 TP-PCR assay (Abbott, Illininois, USA) 
carried out following the manufacturer’s instructions. AGG information was extracted from 
the TP-PCR result if the electropherogram generated an interpretable result. 
Results 
FMR1 CGG repeat structure determination  
To determine the FMR1 repeat structure we performed single-molecule sequencing of PCR 
amplicons from 34 different females and 7 males. Reads-of-insert were generated with a 
minimum of 10 full passes and a mean of 25 full passes. This ensured a high accuracy of the 
final reads-of-insert (Supp. Figure S1). The CGG repeat of the 7 males was supported by a 
mean coverage of 261 [84-614] reads (Supp. Figure S2A). In females, the premutation allele 
contains more CGG units than the normal allele and therefore amplifies worse during PCR. 
Consequently, the premutation will be covered by less reads. The female samples (1-34) had 
a mean coverage of 277 [83-458] and 158 [22-332] for the normal and premutation alleles 
respectively (Supp. Figure S2B-C).  
After sequencing, a de novo assembly was generated for the CGG repeats of the 7 males and 
the sizes of those assemblies were compared to the results from PCR. All assembled repeat 
sizes determined by single molecule sequencing fitted within the error range of PCR control 
runs (± 1 repeat unit up to 54 units, ± 3 repeat units up until 80 CGG units, ±10% of repeat 
size starting from 80 repeats; Figure 2A). Subsequently, the repeat structure was investigated 
(Table 1). For all male samples the number and position of AGG units observed by single 
molecule sequencing was 100% concordant with TP-PCR (Supp. Figure S3A). 
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Next, we investigated whether the repeat size and structure could also be determined for 
females. For 30 females the difference in repeat size between their 2 alleles was larger than 
10 repeat units as previously determined by PCR. For this group we first separated the normal 
from the premutation allele based on differences in read length and subsequently performed a 
de novo assembly on each group of reads separately (Table 2). All assembled normal and 
premutation repeat sizes fell within the error range of PCR (Figure 2B-C). The repeat 
structure of single-molecule sequencing was validated by TP-PCR for 6 females (Supp. 
Figure S3B). 
For 4 females (female 31-34) the difference in repeat size between their 2 alleles was smaller 
than 10 repeats. Although it was still possible to recognize the presence of 2 different alleles 
in the siz distribution of the reads-of-insert, it became difficult to separate the reads derived 
from the different alleles based on this characteristic (Figure 3A). Therefore the de novo 
assembly was performed on the mixture of reads. To make sure both alleles were generated 
by the assembler, also the distribution of the number of AGG interruptions as function of the 
repeat sizes of the individual reads-of-insert were mapped (Figure 3B). In this figure all 
differences in repeat size and the number of AGG units are visualized which allows to 
identify the most frequently occurring repeat structures representing the two female alleles. In 
figure 3B also smaller circles are present flanking the most frequently occurring repeat 
sequences which represent stutter products inherent to PCR amplification of repeat rich 
regions. An overview of the females with small repeat size differences between their alleles 
can be found in Table 3. We also tested PacBio’s Long Amplicon Analysis tool, but this 
performed overall worse than the MIRA assembly pipeline (see supplementary data). 
Precision and robustness of AGG interruption detection  
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The precision of AGG interruption detection was evaluated by investigating the repeatability 
and the intermediate precision by sequencing the PCR product of 3 females 3 times within 
the same sequencing run and spread over independent sequencing experiments. The number 
and position of AGG units in both the normal and premutation allele were always reproduced 
(Table 4). Except for female 17, also the size of the repeats was fully reproducible. In female 
17 a difference of 1 and 2 CGG units for 2 within-run repetitions was found. This small 
variation is caused by the low coverage of the premutation allele of those two samples (7 & 
19 reads respectively, Supp. Figure S2C) and the presence of more stutter in this sample due 
to the large repeat size (99 units). Finally, varying the input DNA concentration before PCR 
did not influence the result (Table 4; female 12). Thus, single-molecule sequencing generates 
results with a high precision and robustness.  
Discussion 
Knowledge of the presence of AGG interruptions is of great value to determine the risk a 
female with a premutation allele will transmit a full mutation to her offspring, especially for 
small premutation alleles (55-85 CGG repeats)(Nolin et al. 2014; Yrigollen et al. 2014). This 
is also increasingly recognized in international guidelines on FMR1 genetic testing 
(Monaghan et al. 2013; Biancalana et al. 2015). Here, we demonstrated that single-molecule 
sequencing enabled not only the determination of the repeat sizes, but also the complete 
repeat structure in male and female gray zone and premutation alleles. The findings of all 
males and females were confirmed, whenever possible, by (TP-)PCR.  
Single-molecule sequencing outperforms current strategies because it allows for an 
unambiguous separation of the normal from the expanded allele which permits the 
determination of the repeat structure for each allele in every male or female. In addition, this 
method is significantly cheaper (± 15 euro/sample) compared to other methods, an advantage 
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which will become even more strong thanks to PacBio’s new Sequel system which is more 
high-throughput and cost-effective as compared to the PacBio RS II used in this study. 
Finally, single-molecule sequencing detects not only AGG interruptions, but any sequence 
variation at the repeat loci. For example, this technology will also identify duplications 
adjacent or within the repeat which are present in some individuals (Mononen et al. 2007) 
and avoid false-negative results sometimes generated by TP-PCR when interruptions are 
present inside a repeat (Braida et al. 2010; Radvansky et al. 2011). As this is an amplicon 
based method, also stutter products will be present next to products with the true repeat size. 
Luckily those stutter products are mainly ± 1 repeat unit and therefore their influence on the 
expansion risk is negligible. In contrast to Loomis et al. (2013) who detected an AGG 
interruption in a plasmid, this is the first study to show the detection of AGG interruptions in 
males and the two alleles of females starting from genomic DNA. 
Knowledge of the risk for FMR1 CGG expansion to occur has a profound impact on 
reproductive choices. Couples at risk for offspring with FXS can choose for prenatal 
diagnosis with possible termination of an affected pregnancy (Burlet et al. 2006). This 
extremely difficult decision is often avoided by couples by not having children or choosing 
assisted reproduction associated with PGD to select only unaffected males or non-carrier 
female embryos. Unfortunately PGD for this indication has always been difficult because 
female carriers are often affected by FXPOI which makes the retrieval of oocytes difficult 
(Burlet et al. 2006). Furthermore the expanded allele cannot be detected in a single cell, 
making PGD for FXS also technically a challenging task, although this can now be overcome 
by using new haplotyping methods (Natesan et al. 2014; Zamani Esteki et al. 2015). The risk 
of expansion will determine which reproductive choices will be made. Therefore easy access 
to accurate AGG information will be extremely valuable in guiding and reassuring couples to 
make the right decisions.  
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In rare cases where women carry two expanded alleles, selection can target the allele with the 
highest risk. We already reported the CGG sequencing result obtained in this study to a 
female (female 34) carrying 2 premutations and who opted for PGD because she carried a 
translocation. The alleles of this woman have a size of 65 and 73 repeats and both carry 2 
AGG interruptions. This knowledge influences the respective risks for expansion and allowed 
selection for the allele with the lowest risk, which is for this woman the allele of 65 repeats 
and 2 AGG interruptions. 
Except for diagnostic use, single-molecule sequencing will also greatly facilitate large-scale 
studies which will be valuable to further fine tune risk estimates on the influence of AGG 
interruptions on the stability of the CGG repeat. Since full mutations can also be amplified 
and single-molecule sequenced (Loomis et al. 2013), AGG interruptions can possibly also be 
detected in this repeat category. Furthermore, recently a method using a PCR-free approach 
to do targeted enrichment was published (Pham et al. 2016), and further improvements can be 
expected in the near future. Those strategies will enable to detect the original repeat size 
distribution and will in addition simultaneously reveal the epigenetic signature of the repeat. 
In conclusion we have demonstrated that single-molecule sequencing correctly determines 
the repeat size of both the normal, gray zone and premutation alleles. Furthermore we also 
detected the number and position of all AGG interruptions not only in males, but also in the 
two alleles of females. Single-molecule sequencing enables for the first time to separate 
unambiguously the two female repeats which enabled the generation of the exact repeat 
structure for both the normal and premutation allele. It seems likely this methodology can 
also be applied to study other tandem repeat expansion disorders where interruptions also 
influence the stability of the allele such as in Friedreich’s ataxia (FRDA; MIM #229300), 
Myotonic dystrophy (DM1; MIM #160900) and different Spinocerebellar ataxia’s (Kroutil et 
al. 1996; Matsuura et al. 2006; Gao et al. 2008; Musova et al. 2009; Braida et al. 2010; 
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Holloway et al. 2011; Yu et al. 2011; Menon et al. 2013). We foresee that this technology 
will replace current tests and has the potential to improve risk estimates allowing for 
improved genetic counseling. 
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Figure Legends 
Figure 1: Overview of the workflow. First, PCR amplicons are generated whereby a different 
barcode is introduced for each amplicon (A). Next, different amplicons are pooled together 
and sequenced by PacBio single-molecule sequencing (B). The long reads generated by 
single-molecule sequencing allow to cross a circulated double-stranded template molecule 
multiple times (C) from which reads-of-insert with a high quality are generated (C). After 
selecting the on-target reads, the distribution of the read sizes of those reads-of insert was 
plotted (D), followed by separating reads-of-insert belonging to the normal allele from the 
premutation allele based on differences in read size (E). Finally, a de novo assembly was 
performed on the separated normal and premutation reads (F) from which the repeat structure 
was extracted (G). Note that the CGG repeat is described as a GGC repeat according to the 
nomenclature of the Human Genome Variation Society (HGVS). 
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Figure 2: Correlation of the repeat size between single-molecule sequencing (Y axis) and 
PCR (X-axis) for: 7 male samples (A). The normal allele of all female samples (B). The grey-
zone/premutation allele of all female samples (C). Samples are indicated by a dot, the grey 
lines show the error range of PCR which is ± 1 repeat unit for repeats smaller than 54 repeat 
units, ± 3 repeat units up until 80 CGG units and ±10% of the repeat size for repeats larger 
than 80 repeats. 
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Figure 3: (A) Distribution of the read sizes of the reads-of insert for female 32 (A). The two 
alleles only differ by 5 repeat units and hence are difficult to separate based on differences in 
the size of the reads-of-insert. (B) Relation between the number of CGG units (X axis) and 
AGG interruptions (Y axis) for the individual reads-of-inserts of female 32. The surface of 
the circles is relative to the number of supporting reads. Some minor circles with the same 
amount of AGG units but a different repeat size can also be observed and represent stutter 
products.  
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Table 1: Repeat characteristics for all male individuals. 
  (TP)-PCR SINGLE-MOLECULE SEQUENCING 
Male # Units # Units  # GGA  Repeat structure* 
1 45 45 0 GGC[45] 
2 52 52 2 GGC[32]GGA[1]GGC[9]GGA[1]GGC[9] 
3 58 60 2 GGC[40]GGA[1]GGC[9]GGA[1]GGC[9] 
4 68 69 2 GGC[49]GGA[1]GGC[9]GGA[1]GGC[9] 
5 76 78 1 GGC[68]GGA[1]GGC[9] 
6 77 79 2 GGC[59]GGA[1]GGC[9]GGA[1]GGC[9] 
7 90 93 2 GGC[73]GGA[1]GGC[9]GGA[1]GGC[9] 
* Genomic DNA change relative to hg19/GRCh37 at g.146993570 (chrX)  
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Table 2: Repeat characteristics for all females with a difference between normal and premutation allele >10 repeat units. 
  
(TP)-PCR SINGLE-MOLECULE SEQUENCING 
NORMAL  PREMUTATION NORMAL  PREMUTATION 
N° # Units # Units # Units  # GGA  Repeat structure* # Units  # GGA   Repeat structure* 
1 29 56 29 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[9] 58 1 GGC[47]GGA[1]GGC[10] 
2 33 51 32 2 
GGC[9]GGA[1]GGC[12]GGA[1]GGC[9] 
51 4 
GGC[10]GGA[1]GGC[9]GGA[1]GGC[9] 
GGA[1]GGC[9]GGA[1]GGC[10] 
3 40 68 40 2 GGC[20]GGA[1]GGC[9]GGA[1]GGC[9] 70 1 GGC[60]GGA[1]GGC[9] 
4 30 65 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 67 0 GGC[67] 
5 30 71 29 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[9] 73 2 GGC[53]GGA[1]GGC[9]GGA[1]GGC[9] 
6 32 68 31 2 GGC[10]GGA[1]GGC[9]GGA[1]GGC[10] 70 2 GGC[50]GGA[1]GGC[9]GGA[1]GGC[9] 
7 31 71 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 72 2 GGC[52]GGA[1]GGC[9]GGA[1]GGC[9] 
8 26 89 26 1 GGC[16]GGA[1]GGC[9] 92 2 GGC[72]GGA[1]GGC[9]GGA[1]GGC[9] 
9 32 60 31 2 GGC[10]GGA[1]GGC[9]GGA[1]GGC[10] 61 1 GGC[49]GGA[1]GGC[11] 
10 31 61 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 64 1 GGC[54]GGA[1]GGC[9] 
11 30 86 29 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[9] 89 1 GGC[79]GGA[1]GGC[9] 
12 31 55 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 55 2 GGC[37]GGA[1]GGC[7]GGA[1]GGC[9] 
13 31 79 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 76 0 GGC[76] 
14 30 89 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 93 2 GGC[73]GGA[1]GGC[9]GGA[1]GGC[9] 
15 31 70 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 72 1 GGC[62]GGA[1]GGC[9] 
16 23 67 23 1 GGC[9]GGA[1]GGC[13] 69 1 GGC[59]GGA[1]GGC[9] 
17 36 99 36 1 GGC[25]GGA[1]GGC[10] 102 1 GGC[92]GGA[1]GGC[9] 
18 31 66 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 69 0 GGC[69] 
19 24 61 24 1 GGC[9]GGA[1]GGC[14] 63 1 GGC[53]GGA[1]GGC[9] 
20 32 77 31 2 GGC[9]GGA[1]GGC[11]GGA[1]GGC[9] 77 1 GGC[67]GGA[1]GGC[9] 
21 32 100 31 2 GGC[10]GGA[1]GGC[9]GGA[1]GGC[10] 104 2 GGC[86]GGA[1]GGC[7]GGA[1]GGC[9] 
22 31 64 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 65 2 GGC[45]GGA[1]GGC[9]GGA[1]GGC[9] 
23 27 52 27 1 GGC[17]GGA[1]GGC[9] 53 2 GGC[33]GGA[1]GGC[9]GGA[1]GGC[9] 
24 31 66 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 67 2 GGC[47]GGA[1]GGC[9]GGA[1]GGC[9] 
25 30 62 29 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[9] 63 2 GGC[43]GGA[1]GGC[9]GGA[1]GGC[9] 
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26 23 60 23 1 GGC[10]GGA[1]GGC[12] 62 2 GGC[42]GGA[1]GGC[9]GGA[1]GGC[9] 
27 34 77 33 2 GGC[13]GGA[1]GGC[9]GGA[1]GGC[9] 81 1 GGC[71]GGA[1]GGC[9] 
28 39 64 39 0 GGC[39] 65 2 GGC[45]GGA[1]GGC[9]GGA[1]GGC[9] 
29 30 60 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 61 1 GGC[51]GGA[1]GGC[9] 
30 20 64 20 1 GGC[9]GGA[1]GGC[10] 64 2 GGC[44]GGA[1]GGC[9]GGA[1]GGC[9] 
* Genomic DNA change relative to hg19/GRCh37 at g.146993570 (chrX) 
 
 
Table 3: Repeat characteristics for four females with similarly sized repeats. 
  
 
(TP)-PCR SINGLE-MOLECULE SEQUENCING 
ALLELE 1 ALLELE 2 ALLELE 1 ALLELE 2 
N° # Units # Units # Units  # GGA  Repeat structure* # Units  # GGA  Repeat structure* 
31 41 46 41 2 GGC[20]GGA[1]GGC[9]GGA[1]GGC[10] 45 2 GGC[25]GGA[1]GGC[9]GGA[1]GGC[9] 
32 42 47 42 1 GGC[21]GGA[1]GGC[20] 47 2 GGC[27]GGA[1]GGC[9]GGA[1]GGC[9] 
33 40 45 41 2 GGC[21]GGA[1]GGC[9]GGA[1]GGC[9] 43 2 GGC[23]GGA[1]GGC[9]GGA[1]GGC[9] 
34 65 73 65 2 GGC[45]GGA[1]GGC[9]GGA[1]GGC[9] 74 2 GGC[56]GGA[1]GGC[7]GGA[1]GGC[9] 
* Genomic DNA change relative to hg19/GRCh37 at g.146993570 (chrX)  
 
 
 
 
 
  
This article is protected by copyright. All rights reserved. 
Table 4: Repeat characteristics for 3 females repeated both within and between different sequencing runs and with different DNA concentrations. 
 
(TP)-PCR SINGLE-MOLECULE SEQUENCING 
NORMAL  PREMUTATION NORMAL PREMUTATION 
N° Run  
Input 
(ng/ul) # Units # Units # Units  # GGA  Repeat structure* # Units  # GGA  Repeat structure* 
2 1 40 33 51 32 2 GGC[9]GGA[1]GGC[12]GGA[1]GGC[9] 51 4 
GGC[10]GGA[1]GGC[9]GGA[1] 
GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 
  2 40 33 51 32 2 GGC[9]GGA[1]GGC[12]GGA[1]GGC[9] 51 4 
GGC[10]GGA[1]GGC[9]GGA[1] 
GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 
  2 40 33 51 32 2 GGC[9]GGA[1]GGC[12]GGA[1]GGC[9] 51 4 
GGC[10]GGA[1]GGC[9]GGA[1] 
GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 
  2 40 33 51 32 2 GGC[9]GGA[1]GGC[12]GGA[1]GGC[9] 51 4 
GGC[10]GGA[1]GGC[9]GGA[1] 
GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 
  3 40 33 51 32 2 GGC[9]GGA[1]GGC[12]GGA[1]GGC[9] 51 4 
GGC[10]GGA[1]GGC[9]GGA[1] 
GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 
12 1 40 31 55 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 55 2 GGC[37]GGA[1]GGC[7]GGA[1]GGC[9] 
  2 40 31 55 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 55 2 GGC[37]GGA[1]GGC[7]GGA[1]GGC[9] 
  2 40 31 55 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 55 2 GGC[37]GGA[1]GGC[7]GGA[1]GGC[9] 
  2 40 31 55 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 55 2 GGC[37]GGA[1]GGC[7]GGA[1]GGC[9] 
  3 40 31 55 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 55 2 GGC[37]GGA[1]GGC[7]GGA[1]GGC[9] 
  3 5 31 55 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 55 2 GGC[37]GGA[1]GGC[7]GGA[1]GGC[9] 
  3 100 31 55 30 2 GGC[9]GGA[1]GGC[9]GGA[1]GGC[10] 55 2 GGC[37]GGA[1]GGC[7]GGA[1]GGC[9] 
17 1 40 36 99 36 1 GGC[25]GGA[1]GGC[10] 104 1 GGC[94]GGA[1]GGC[9] 
  2 40 36 99 36 1 GGC[25]GGA[1]GGC[10] 102 1 GGC[92]GGA[1]GGC[9] 
  2 40 36 99 36 1 GGC[25]GGA[1]GGC[10] 103 1 GGC[93]GGA[1]GGC[9] 
  2 40 36 99 36 1 GGC[25]GGA[1]GGC[10] 104 1 GGC[94]GGA[1]GGC[9] 
  3 40 36 99 36 1 GGC[25]GGA[1]GGC[10] 104 1 GGC[94]GGA[1]GGC[9] 
* Genomic DNA change relative to hg19/GRCh37 at g.146993570 (chrX)  
 
